Stonebridge Financial Group (Pennsylvania)’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,217
Closed -$220K 421
2025
Q1
$220K Buy
3,217
+2,909
+944% +$237K 0.02% 209
2024
Q4
$24K Buy
+308
New +$22.8K ﹤0.01% 471

Other funds holding DXCM

Stonebridge Financial Group (Pennsylvania)'s DXCM Position: Q2 2025 in Review

Stonebridge Financial Group (Pennsylvania) sold out of DexCom (DXCM) in Q2 2025, closing a stake of 3,217 shares — an estimated $220K sold.

Stonebridge Financial Group (Pennsylvania) first reported a position in DXCM in Q4 2024 and held it in 2 quarters. The position peaked at $220K in Q1 2025. 939 funds tracked by Wall St. Rank hold DXCM as of Q2 2025.

  • Stonebridge Financial Group (Pennsylvania) reported no remaining DexCom position as of Q2 2025 after selling out during the quarter.
  • Stonebridge Financial Group (Pennsylvania) sold 3,217 DexCom shares in Q2 2025, an estimated $220K.
  • Stonebridge Financial Group (Pennsylvania) first reported a position in DexCom in Q4 2024 and held it in 2 quarters.
  • Stonebridge Financial Group (Pennsylvania)'s DexCom position peaked at $220K in Q1 2025.
  • 939 funds tracked by Wall St. Rank held DexCom as of Q2 2025.

Based on Stonebridge Financial Group (Pennsylvania)'s 13F filing for Q2 2025, filed 24 Jul 2025.